{"AmendmentNumber":"1320","ParentBillNumber":"H5500","Bill":null,"Sponsor":{"Id":"BHJ1","Name":"Bradley H. Jones, Jr.","Type":1,"Details":"https://malegislature.gov/api/GeneralCourts/194/LegislativeMembers/BHJ1","ResponseDate":"2026-04-16T14:07:44.577"},"Category":"Public Health","Action":"Consolidated","RollCall":[],"Title":"Mandatory Fentanyl Testing","Branch":"House","RedraftNumber":null,"IsFurther":false,"GeneralCourtNumber":194,"Text":"Representatives Jones of North Reading, Ferguson of Holden, Frost of Auburn, Muradian of Grafton, Vieira of Falmouth and Smola of Warren move to amend the bill by adding the following section:- \r\n\"Section XX. Chapter 111 of the General Laws, as most recently amended by section 40 of chapter 14 of the acts of 2025, is hereby further amended by inserting after Section 249 the following new section:-\r\n\r\nSECTION 250. Fentanyl testing\r\n\r\n(a) If a person is treated at a general acute care hospital and the hospital conducts a urine drug screening to assist in diagnosing the patient’s condition, the hospital shall include testing for fentanyl in the urine drug screening.\r\n\r\n(b) As used in this section, “urine drug screening” means a chemical analysis intended to test patients for the presence of multiple drugs, including cocaine, opioids, and phencyclidine.\r\n\r\n(c) The department of public health is hereby authorized and directed to promulgate or revise any regulations necessary to implement the testing requirements outlined above. \"\r\n"}